bimekizumab
ucb pharmaceuticals
['psoriatic arthritis', 'bimekizumab']
new long-term data on bimekizumab in psoriatic arthritis and axial spondyloarthritis presented at eular 2023 #pharma #lifesciences #biotech #clinicalresearch #news #pharmiweb 
News from across the pharmaceutical and biotech industry from PharmiWeb https://t.co/ea1b58MZYg